Facebook
Twitter
LinkedIn
Forward
We are at a unique place in obesity care history where anti-obesity medications (AOMs) are showing promising, clinically significant weight loss for persons with obesity.
|
This presentation will provide an overview of the evidence basis for using continuous glucose monitoring (CGM) in patients with obesity.
|
Weight stigma is an often-overlooked contributor to poor patient engagement and weight gain over time.
|
As the tools continue to advance in Obesity Medicine, it can be easy to overlook the importance of the Behavior pillar in treating obesity.
|
|
OMA Clinical Practice Statement Updates - Harold Bays, MD, FOMA, Lydia Alexander, MD, FOMA, Karlijn Burridge, PA-C, Suzanne Cuda, MDCME/CE Expiration Date: 3/19/25
|